Clinical Trials Logo

Clinical Trial Summary

Purpose : The aim of the study is to investigate the effects of cox inhibitors as a rescue agent against the rocuronium pain Methodology : Sixty patients enrolled for the general anesthesia enrolled in this study. Patients were allocated into two groups (Group 1: Dexketoprofen group, Group 2: Control group) .Pain was evaluated by during rocuronium injection, patients were scored by a scale showed below. 0;No movement response to injection 1. Mild movement response to injection 2. Hand withdrawal response to injection 3. Arm withdrawal response to injection Investigators also evaluated the pain with 2 questions when the patient was in the recovery room. Question 1.What was the last feeling before participants fall into sleep? question 2. Did participants feel any pain on participants's hand during medication injection for anesthesia?


Clinical Trial Description

Purpose : Rocuronium bromide is a painful agent while general anesthesia induction. The aim of the study is to investigate the effects of cox inhibitors as a rescue agent against the rocuronium pain Methodology : Sixty patients enrolled for the general anesthesia enrolled in this study. Patients were allocated into two groups (Group 1: Dexketoprofen group, Group 2: Control group) .Pain was evaluated by during rocuronium injection, patients were scored by a scale showed below. 0;No movement response to injection 1. Mild movement response to injection 2. Hand withdrawal response to injection 3. Arm withdrawal response to injection Investigators also evaluated the pain with 2 questions when the patient was in the recovery room. Question 1.What was the last feeling before participants fall into sleep? question 2. Did participants feel any pain on participants's hand during medication injection for anesthesia? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04582032
Study type Interventional
Source Ankara City Hospital Bilkent
Contact
Status Completed
Phase N/A
Start date November 1, 2020
Completion date January 4, 2021

See also
  Status Clinical Trial Phase
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Not yet recruiting NCT05109000 - Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline Phase 4
Completed NCT02524743 - The Prevention of Pain Associated With Rocuronium Injection Phase 4
Completed NCT04673500 - Assessment of Pain on Propofol Injection. N/A
Recruiting NCT05378113 - Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial Phase 2
Completed NCT01824758 - Effect of Esmolol on Pain Due to Rocuronium Phase 4
Completed NCT04555980 - Warm Patch Decrease Propofol Injection Pain N/A
Completed NCT04436666 - Virtual Reality, Ice Application and Self-injection and Self-test Fair, Pain and State Anxiety N/A
Recruiting NCT03420560 - A Warmer Temperature Decrease Propofol Injection Pain N/A
Completed NCT05225610 - Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy N/A
Recruiting NCT05221333 - Sorrel 25R Injector - Sorrel Clinical Study Protocol N/A
Recruiting NCT05269823 - Topical Ice-therapy for Intravitreal Injections N/A